The deal slashes the price of a two-dose pack of FDA-approved naloxone to $24, enabling California to purchase more of the life-saving medication using opioid settlement funds.
The reduced price does not impact the cost for everyday shoppers, but it allows California to distribute more naloxone to eligible non-profits, schools, and police departments.
California's Governor praised the agreement with Amneal Pharmaceuticals, paralleling it to the state's efforts in providing insulin at discounted rates, aiming for transparent and lower drug prices.
In 2022, California witnessed a significant number of opioid-related deaths, with the majority attributed to fentanyl, emphasizing the critical need for accessible naloxone.
[
add
]
[
|
|
...
]